These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 7738642)

  • 1. Preoperative scintigraphy and operative probe scintimetry of colorectal carcinoma using technetium-99m-88BV59.
    Moffat FL; Vargas-Cuba RD; Serafini AN; Jabir AM; Sfakianakis GN; Sittler SY; Robinson DS; Crichton VZ; Subramanian R; Murray JH
    J Nucl Med; 1995 May; 36(5):738-45. PubMed ID: 7738642
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radioimmunoscintigraphy of recurrent, metastatic, or occult colorectal cancer with technetium 99m-labeled totally human monoclonal antibody 88BV59: results of pivotal, phase III multicenter studies.
    Serafini AN; Klein JL; Wolff BG; Baum R; Chetanneau A; Pecking A; Fischman AJ; Hoover HC; Wynant GE; Subramanian R; Goroff DK; Hanna MG
    J Clin Oncol; 1998 May; 16(5):1777-87. PubMed ID: 9586891
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human monoclonal antibody 99mTc-88BV59: detection of colorectal cancer, recurrent or metastatic disease and immunogenicity assessment.
    Krause BJ; Baum RP; Staib-Sebler E; Lorenz M; Niesen A; Hör G
    Eur J Nucl Med; 1997 Jan; 24(1):72-5. PubMed ID: 9044881
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Technetium 99m-labeled IMMU-4, a monoclonal antibody against carcinoembryonic antigen, for imaging of occult recurrent colorectal cancer in patients with rising serum carcinoembryonic antigen levels.
    Patt YZ; Podoloff DA; Curley S; Kasi L; Smith R; Bhadkamkar V; Charnsangavej C
    J Clin Oncol; 1994 Mar; 12(3):489-95. PubMed ID: 8120546
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radioimmunoscintigraphy of colorectal carcinoma using technetium-99m-labeled, totally human monoclonal antibody 88BV59H21-2.
    Gulec SA; Serafini AN; Moffat FL; Vargas-Cuba RD; Sfakianakis GN; Franceschi D; Crichton VZ; Subramanian R; Klein JL; De Jager RL
    Cancer Res; 1995 Dec; 55(23 Suppl):5774s-5776s. PubMed ID: 7493345
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radioimmunoscintigraphy of recurrent, metastatic, or occult colorectal cancer with technetium Tc 99m 88BV59H21-2V67-66 (HumaSPECT-Tc), a totally human monoclonal antibody. Patient management benefit from a phase III multicenter study.
    Wolff BG; Bolton J; Baum R; Chetanneau A; Pecking A; Serafini AN; Fischman AJ; Hoover HC; Klein JL; Wynant GE; Subramanian R; Goroff DK; Hanna MG
    Dis Colon Rectum; 1998 Aug; 41(8):953-62. PubMed ID: 9715149
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current status of cancer immunodetection with radiolabeled human monoclonal antibodies.
    De Jager R; Abdel-Nabi H; Serafini A; Pecking A; Klein JL; Hanna MG
    Semin Nucl Med; 1993 Apr; 23(2):165-79. PubMed ID: 8511602
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lesion-by-lesion comparison of computerized tomography and indium-111-labeled monoclonal antibody C110 radioimmunoscintigraphy in colorectal carcinoma: a multicenter trial.
    Divgi CR; McDermott K; Griffin TW; Johnson DK; Schnobrich KE; Fallone PS; Scott AM; Hilton S; Cohen AM; Larson SM
    J Nucl Med; 1993 Oct; 34(10):1656-61. PubMed ID: 8410278
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of colorectal carcinoma by anti-CEA monoclonal antibody (IOR-CEA1) labeled with 99mTc scintigraphy.
    Sirisriro R; Boonkitticharoen V; Kraiphibul P; Ratanatharathorn V; Sumboonnanon K; Kanjanapitak A; Kuhapremma T; Sritara C; Puchinda D; Chouplywech P; Jalayondeja V; Pekanan P; Rochanawutanon M; Intaramarn C; Ayudhya AN; Chokesuwathana P
    Hepatogastroenterology; 2000; 47(32):405-13. PubMed ID: 10791201
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Value of radioimmunoscintigraphy with technetium-99m labelled anti-CEA monoclonal antibody (BW431/26) in the detection of colorectal cancer.
    Poshyachinda M; Chaiwatanarat T; Saesow N; Thitathan S; Voravud N
    Eur J Nucl Med; 1996 Jun; 23(6):624-30. PubMed ID: 8662095
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radioimmunodetection of colorectal carcinoma using technetium-99m-labeled Fab' fragments of the IMMU-4 anti-carcinoembryonic antigen monoclonal antibody.
    Moffat FL; Vargas-Cuba RD; Serafini AN; Casillas VJ; Morillo G; Benedetto P; Robinson DS; Ardalan B; Manten HD; Clark KC
    Cancer; 1994 Feb; 73(3 Suppl):836-45. PubMed ID: 8306268
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Semiquantitative SPECT tumor uptake of technetium-99m-labeled anti-CEA monoclonal antibody in colorectal tumor.
    Oriuchi N; Endo K; Watanabe N; Sugiyama S; Asao T; Takenoshita S; Nagamachi Y; Baum RP
    J Nucl Med; 1995 Apr; 36(4):679-83. PubMed ID: 7699464
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Operative probe scintimetry with indium and technetium for colorectal cancer.
    Kuhn JA; Nochumson J
    J Surg Oncol; 2007 Sep; 96(4):290-6. PubMed ID: 17879338
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A thousand points of light or just dim bulbs? Radiolabeled antibodies and colorectal cancer imaging.
    Moffat FL; Gulec SA; Serafini AN; Sfakianakis GN; Pop R; Robinson DS; Franceschi D; Boggs J; Livingstone AS
    Cancer Invest; 1999; 17(5):322-34. PubMed ID: 10370360
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of immunoscintigraphy and computerized tomography in identifying colorectal cancer: individual lesion analysis.
    Corbisiero RM; Yamauchi DM; Williams LE; Esteban JM; Odom-Maryon T; Beatty JD
    Cancer Res; 1991 Oct; 51(20):5704-11. PubMed ID: 1913688
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Imaging of colorectal carcinoma with technetium-99m radiolabeled Fab' fragments.
    Podoloff DA; Patt YZ; Curley SA; Kim EE; Bhadkamkar VA; Smith RE
    Semin Nucl Med; 1993 Apr; 23(2):89-98. PubMed ID: 8511605
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The value of radioimmunoscintigraphy compared to computed tomography in the diagnosis and relapse diagnosis of colorectal tumors].
    Barzen G; Zwicker C; Neumann K; Löhde E; Raakow R; Böse-Landgraf W; Richter W; Hierholzer J; Langer M; Felix R
    Rofo; 1992 Jan; 156(1):3-10. PubMed ID: 1733472
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radioimmunoscintigraphy of colorectal carcinomas with 99mTc-labelled antibodies.
    Artiko V; Petrović M; Sobić-Saranović D; Antić A; Koljević-Marković A; Krajnović-Jaksić E; Saranović D; Petrović N; Stojković M; Durutović D; Zuvela M; Radovanović-Bobić A; Galun D; Petrasinović Z; Pavlović S; Krivokapić Z; Obradović V
    Hepatogastroenterology; 2011; 58(106):347-51. PubMed ID: 21661394
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of carcinoembryonic antigen radioimmunodetection and computed tomography for predicting the resectability of recurrent colorectal cancer.
    Hughes K; Pinsky CM; Petrelli NJ; Moffat FL; Patt YZ; Hammershaimb L; Goldenberg DM
    Ann Surg; 1997 Nov; 226(5):621-31. PubMed ID: 9389396
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of complete versus fragmented technetium-99m-labeled anti-CEA monoclonal antibodies for immunoscintigraphy in colorectal cancer.
    Behr TM; Becker WS; Bair HJ; Klein MW; Stühler CM; Cidlinsky KP; Wittekind CW; Scheele JR; Wolf FG
    J Nucl Med; 1995 Mar; 36(3):430-41. PubMed ID: 7884505
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.